Phuong Nguyen
Psychiatry · Marrero, LANPI 1356431761
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 633 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 633 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$828
- Otsuka America Pharmaceutical, Inc.$827
- Alkermes, Inc.$791
- Lundbeck LLC$578
- plus $5K from 32 others
What the payments were for
- Food & beverage$11,140100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 142 | $2,354 |
| Takeda Pharmaceuticals U.S.A., Inc. | 60 | $1,027 |
| Johnson & Johnson | 56 | $828 |
| Otsuka America Pharmaceutical, Inc. | 45 | $827 |
| Alkermes, Inc. | 52 | $791 |
| Lundbeck LLC | 32 | $578 |
| Noven Therapeutics, LLC | 25 | $428 |
| Novo Nordisk | 26 | $421 |
| Axsome Therapeutics, Inc. | 21 | $399 |
| Almatica Pharma LLC | 20 | $388 |
| Sunovion Pharmaceuticals Inc. | 19 | $377 |
| Supernus Pharmaceuticals, Inc. | 9 | $372 |
| Corium, LLC | 23 | $372 |
| Boston Scientific | 2 | $232 |
| Eisai Inc. | 14 | $205 |
| Tris Pharma Inc | 11 | $184 |
| Idorsia Pharmaceuticals US Inc | 11 | $180 |
| Ironshore Pharmaceuticals Inc. | 8 | $149 |
| Shire North American Group Inc | 10 | $148 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $130 |
| GSK | 7 | $126 |
| Bayer | 8 | $124 |
| Stryker | 1 | $105 |
| Merck | 4 | $67 |
| Lilly USA, LLC | 3 | $48 |
| AstraZeneca | 2 | $43 |
| Neurocrine Biosciences, Inc. | 3 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Amarin Pharma, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Eyevance Pharmaceuticals LLC | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Amgen | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Bioxcel Therapeutics, Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$166
- SPINEJACK$105
- MULTIGEN 2$105
- mild Device Kit$105
How this compares
$11,149 in reported general payments places this provider in the 95th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $95,128 |
| VraylarCariprazine Hcl | 12 | $17,748 |
| AuvelityDextromethorphan Hbr/Bupropion | 11 | $11,547 |
| Lisdexamfetamine Dimesylate | 15 | $4,116 |
| Duloxetine Hcl | 111 | $3,375 |
| Bupropion XlBupropion Hcl | 92 | $2,345 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 83 | $2,011 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 46 | $1,862 |
| Divalproex Sodium ErDivalproex Sodium | 24 | $1,436 |
| Mirtazapine | 75 | $1,048 |
| Aripiprazole | 30 | $837 |
| Methylphenidate Hcl | 34 | $814 |
| Olanzapine | 25 | $752 |
| Trazodone Hcl | 80 | $734 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $40 | $95,12812 claims |
| AbbVieVraylar | $2,354 | $17,74812 claims |
| Axsome Therapeutics, Inc.Auvelity | $399 | $11,54711 claims |
| Lilly USA, LLCOlanzapine | $48 | $75225 claims |
| Almatica Pharma LLCSertraline Hcl | $388 | $33649 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 474 psychiatry providers in Louisiana.
Other psychiatry in Marrero
- Patrick HayesLake Charles$837K
- Maria CruseThibodaux$522K
- Larry WarnerBaton Rouge$495K
- Gregory BrownShreveport$495K
- Arwen PodestaNew Orleans$466K
- Jasjit SinghShreveport$420K
- Roger BrownMandeville$216K
- Abdul KhanBaton Rouge$156K
- William ColombMandeville$117K
- Andrew MorsonNew Orleans$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.